Dr. Fidler obtained his PhD from the University of Utah under the supervision of Dr. E. Dale Able. His work focused on understanding how bioenergetic metabolism alters platelet function in thrombosis and inflammatory conditions. Dr. Fidler then moved to Columbia University to work with Dr. Alan Tall on understanding how dysfunctional hematopoiesis promotes atherosclerosis. Dr. Fidler then moved to UCSF in the summer of 2023 to start the Fidler Lab focused on understanding how dysfunctional hematopoiesis and genetic risk factors can promote cardiovascular disease.
Cesar received his bachelor’s degree in Exercise Science at California State University Northridge where he investigated DNA binding by terpyridine-based anti-tumor agents. He earned his doctorate in Integrative and Biomedical Physiology at Pennsylvania State University where he researched how NLRP3 gene loss impacts left ventricle physiology in salt-sensitive hypertension. He joined the Fidler Lab in Spring 2024 as a postdoctoral scholar to continue investigating how immune system dysregulation contributes to cardiovascular disease.
Jun received a bachelor's degree in Biochemistry at UCLA. Her first research experience was at the Gomperts Lab in her undergraduate, studying the proliferative response of neuroendocrine stem cells following acute injury in the lung epithelium. She then worked in industry as a research associate on the drug metabolism and pharmacokinetics team. In pursuit of her academic aspirations, she joined the Fidler lab in the fall of 2023 to determine her research interests prior to applying for a PhD program.
